Meta-analysis of bevacizumab therapy in recurrent glioblastoma multiforme shows associations with improved outcomes
Bevacizumab therapy linked to better survival and fewer bleeding risks in recurrent brain cancer
This meta-analysis evaluates bevacizumab (BEV) therapy, temozolomide (TMZ), and lomustine in patients with recurrent glioblastoma multiforme…
A large review of patients with recurrent brain cancer found bevacizumab therapy linked to better survival and fewer bleeding risks compared…
Recurrence patterns in high-grade glioma after standard chemoradiotherapy: a retrospective review
Why tumors grow back inside the radiation beam, not just at the edges
This retrospective single-center review of 41 patients with high-grade glioma found that central recurrence was the most common pattern (36.…
New data shows brain tumors often return in the middle of the radiation zone, suggesting biology, not just targeting errors, drives failure.
Narrative review on ferroptosis-targeting strategies for glioblastoma modulation
New Brain Tumor Strategy Targets Iron to Boost Immune Attack
This narrative review synthesizes mechanisms and strategies for targeting ferroptosis in glioblastoma. It highlights potential to enhance an…
This new approach uses the tumor's own iron problem to help the body's immune system destroy cancer cells more effectively.
Bibliometric analysis maps 4.3-fold rise in elderly glioma research, highlights MGMT focus
Why is brain tumor research for older adults lagging behind? A new analysis reveals a critical gap.
A bibliometric analysis of 1,299 publications found a 4.3-fold increase in research on elderly glioma from 2001 to 2025, with the U.S., Ital…
Glioma research for older adults lags behind because studies focus on younger patients, leaving a critical gap in treating aggressive tumors…